Chuang Hao-Yuan has reported the acquisition of 5,000 shares of Belite Bio, Inc. This transaction, filed on October 30, 2026, is part of a restricted stock unit (RSU) award that vested due to the satisfaction of performance criteria.

Background

Chuang Hao-Yuan is a reporting owner associated with Belite Bio, Inc., a company involved in the pharmaceutical preparations sector. The recent filing indicates that Chuang is both a director and the Chief Financial Officer of Belite Bio, which trades under the ticker symbol BLTE.

What the Filing Says

The filing states, "On September 15, 2025, the reporting person was granted an award of restricted stock units (RSUs) which shall vest upon satisfaction of several performance criteria. Certain of these performance criteria were met on 10/29/2026, resulting in vesting of the RSUs as to 5,000 ordinary shares." Following this transaction, Chuang Hao-Yuan now owns 180,264 shares directly.

Impact

This acquisition may impact Belite Bio's shareholders by reinforcing confidence in the company's leadership and strategic direction. It also highlights the importance of aligning executive interests with those of shareholders, a practice that is becoming increasingly common in the pharmaceutical preparations industry.

What's Next

The filing does not say what happens next.

Ownership Details

In addition to the 5,000 shares acquired through the RSU award, Chuang Hao-Yuan holds a total of 180,264 shares directly following this transaction. It is noteworthy that prior to this acquisition, Chuang had transferred 30,000 ordinary shares to ESHJ Ltd, a company that is wholly beneficially owned by him, on June 8, 2026. This transfer is significant as it illustrates Chuang's strategic management of his equity stake in Belite Bio.

Company Information

Belite Bio, Inc. is incorporated in the state of E9 and operates within the pharmaceutical preparations industry, classified under the Standard Industrial Classification code 2834. The company is headquartered at 12750 High Bluff Drive, Suite 475, San Diego, CA 92130, and can be reached at the business phone number 858-246-6240.

Reporting Owner's Role

Chuang Hao-Yuan serves as both a director and the Chief Financial Officer of Belite Bio, indicating a significant leadership role within the company. His dual position as an officer and director underscores his influence on the company’s financial strategies and overall governance.

Filing Context

The filing does not provide information about the specific performance criteria that were met for the RSUs to vest, nor does it detail any future plans or intentions regarding Chuang's ownership stake in Belite Bio, Inc.